What this means for nursing mothers considering semaglutide The study provides the first direct human evidence that subcutaneous semaglutide does not appear to transfer into breast milk at clinically meaningful levels
New fluorinated pyrrolidine and azetidine amides as dipeptidyl peptidase IV inhibitors
These include: shortness of breath swelling or fluid retention (buildup of fluid in your body) rapid increase in weight unusual tiredness If you notice any of these heart failure symptoms yourself, tell your doctor right away
In case of statin intolerance, ezetimibe (or combination therapy in partial intolerance) is a treatment option
If you are taking these medications for diabetes management, additional considerations may apply, though well-controlled diabetes (even with insulin use) is generally compatible with donation if other criteria are met
[5] GLP-1 agonist market in the UK and Europe In the UK, the GLP-1 receptor agonist market reached a revenue of $847 million USD in 2024, with an expected revenue of $2.2 billion by 2030 and a CAGR of 16% between 2025 and 2030